Author:
Robelin Patrick,Hadoux Julien,Forestier Julien,Planchard David,Hervieu Valérie,Berdelou Amandine,Scoazec Jean-Yves,Valette Pierre-Jean,Leboulleux Sophie,Ducreux Michel,Lombard-Bohas Catherine,Baudin Eric,Walter Thomas
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference40 articles.
1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017
2. Neuroendocrine tumors of the lung: an update;Rekhtman;Arch Pathol Lab Med,2010
3. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids;Caplin;Ann Oncol,2015
4. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification;Travis;J Thorac Oncol,2015
5. Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial;Ferolla;Lancet Oncol,2017
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献